Tübingen / 18.08.2022 Manfred Ulmer-Weber has been appointed to the management board of SHS Gesellschaft für Beteiligungsmanagement mbH. Ulmer-Weber will be jointly responsible for the allocation of the new SHS VI fund of the Tübingen-based sector specialist. The additional Managing Partner is an SHS home-grown and started his career at SHS in 2010. The shareholders […]

SHS Gesellschaft für Beteiligungsmanagement has received capital commitments of over 220 million euros for its sixth fund at the first closing. Faster than expected, the Tübingen-based healthcare investor has already exceeded its target of 200 million euros at the first closing. The sixth SHS fund generation also aims at majority and minority investments in the […]

Pneumology deals with diseases of the respiratory tract and is a speciality of internal medicine. The word is derived from the Greek: pneumo = lung, logia = study. In medicine, the subject of pulmonary medicine has received special attention in the last two years through COVID-19. The history of pneumology begins much earlier, of course. […]

SHS is pleased to offer students a practical experience through an internship and to give you an insight into the areas of private equity, funds and growth companies. Simeon Liesenfeld has been an intern at SHS since the beginning of April 2022. Simeon is currently completing his bachelor’s degree in industrial engineering at the Karlsruhe […]

Kerstin Stuck is a new analyst in the SHS team. She is a biologist and business economist by training and thus doubly qualified to assess investment enquiries. In her spare time, she tends to her vegetable garden and chickens when she is not touring Europe in her caravan with her husband and children.

As a healthcare investor, SHS supports its portfolio companies not only with capital, but also with decades of experience and expertise in the healthcare sector. We wanted to know from Dr André Zimmermann, SHS partner and doctor of microbiology, what SHS specifically does for its portfolio companies. Editor: In which areas, apart from capital, does […]

The approval of the worldwide unique, double-walled high pressure balloon catheter “OPN-NC Super High Pressure PTCA Balloon” is a big step for SIS and very good news for all patients in the USA who are affected by serious lesions in the area of the heart vessels. More than 100,000 patients in Europe have already been […]

Advanced Osteotomy Tools AG (AOT), a highly innovative healthcare company in the field of laser-based contactless surgical robots, has a new, highly experienced CEO in Elmar Zurbriggen. Zubriggen took office on 1 April and has previously held responsibilities at various medtech world market leaders. Peter Oprandi, the new CFO, also brings a lot of experience […]

SHS enjoys a very good reputation as a specialised medtech investor among companies and institutional investors because we draw on a strong network of experts. The medical-technical healthcare experts who support SHS and the portfolio companies play a special role. We would like to introduce you to some of our healthcare experts in short interviews […]

We would like to introduce you to the SHS portfolio companies in a new series. We start with SIS Medical AG, a leading Swiss manufacturer of balloon catheters for interventional dillatation of the coronary vessels. Dr Sergej Kammerzell has been CEO at SIS for two years; he is a human physician and holds a doctorate […]

This year we once again hosted the annual Investors’ Day and the shareholders’ meetings of the SHS Funds. To our great pleasure, it was again possible this year to hold the event in the presence of the investors. Investors, portfolio representatives, our senior advisors and healthcare experts were invited to the Hotel Krone in the […]

Digital health applications (DiGA) can improve medical care.